BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37815175)

  • 21. Letter to the editor concerning the article 'Association between rotavirus vaccination and risk of intussusception among neonates and infants: a systematic review and meta-analysis' (JAMA Netw Open. 2019;2(10):e1912458).
    Benninghoff B; Pereira P; Willame C
    Hum Vaccin Immunother; 2020 Oct; 16(10):2502-2503. PubMed ID: 32186946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
    Lloyd-Johnsen C; Justice F; Donath S; Bines JE
    Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intussusception following rotavirus vaccination in the Valencia Region, Spain.
    Pérez-Vilar S; Díez-Domingo J; Puig-Barberà J; Gil-Prieto R; Romio S
    Hum Vaccin Immunother; 2015; 11(7):1848-52. PubMed ID: 26083707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022.
    Anwari P; Burnett E; Chavers TP; Samsor A; Safi H; Safi N; Clark AD; Parashar UD; Tate JE
    Vaccine; 2024 Mar; 42(8):2059-2064. PubMed ID: 38413278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
    Tate JE; Mwenda JM; Armah G; Jani B; Omore R; Ademe A; Mujuru H; Mpabalwani E; Ngwira B; Cortese MM; Mihigo R; Glover-Addy H; Mbaga M; Osawa F; Tadesse A; Mbuwayesango B; Simwaka J; Cunliffe N; Lopman BA; Weldegebriel G; Ansong D; Msuya D; Ogwel B; Karengera T; Manangazira P; Bvulani B; Yen C; Zawaira FR; Narh CT; Mboma L; Saula P; Teshager F; Getachew H; Moeti RM; Eweronu-Laryea C; Parashar UD;
    N Engl J Med; 2018 Apr; 378(16):1521-1528. PubMed ID: 29669224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.
    Patel MM; López-Collada VR; Bulhões MM; De Oliveira LH; Bautista Márquez A; Flannery B; Esparza-Aguilar M; Montenegro Renoiner EI; Luna-Cruz ME; Sato HK; Hernández-Hernández Ldel C; Toledo-Cortina G; Cerón-Rodríguez M; Osnaya-Romero N; Martínez-Alcazar M; Aguinaga-Villasenor RG; Plascencia-Hernández A; Fojaco-González F; Hernández-Peredo Rezk G; Gutierrez-Ramírez SF; Dorame-Castillo R; Tinajero-Pizano R; Mercado-Villegas B; Barbosa MR; Maluf EM; Ferreira LB; de Carvalho FM; dos Santos AR; Cesar ED; de Oliveira ME; Silva CL; de Los Angeles Cortes M; Ruiz Matus C; Tate J; Gargiullo P; Parashar UD
    N Engl J Med; 2011 Jun; 364(24):2283-92. PubMed ID: 21675888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.
    Carlin JB; Macartney KK; Lee KJ; Quinn HE; Buttery J; Lopert R; Bines J; McIntyre PB
    Clin Infect Dis; 2013 Nov; 57(10):1427-34. PubMed ID: 23964090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.
    Fotso Kamdem A; Vidal C; Pazart L; Leroux F; Pugin A; Savet C; Sainte-Claire Deville G; Guillemot D; Massol J
    Vaccine; 2019 Jul; 37(32):4587-4593. PubMed ID: 30851968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intussusception risk after rotavirus vaccination in U.S. infants.
    Yih WK; Lieu TA; Kulldorff M; Martin D; McMahill-Walraven CN; Platt R; Selvam N; Selvan M; Lee GM; Nguyen M
    N Engl J Med; 2014 Feb; 370(6):503-12. PubMed ID: 24422676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.
    Belongia EA; Irving SA; Shui IM; Kulldorff M; Lewis E; Yin R; Lieu TA; Weintraub E; Yih WK; Li R; Baggs J;
    Pediatr Infect Dis J; 2010 Jan; 29(1):1-5. PubMed ID: 19907356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of rotavirus vaccine on paediatric rotavirus hospitalisation and intussusception in New Zealand: A retrospective cohort study.
    McIlhone KA; Best EJ; Petousis-Harris H; Howe AS
    Vaccine; 2020 Feb; 38(7):1730-1739. PubMed ID: 31889608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies.
    Kassim P; Eslick GD
    Vaccine; 2017 Jul; 35(33):4276-4286. PubMed ID: 28648544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intussusception risk following oral monovalent rotavirus vaccination in 3 Asian countries: A self-control case series evaluation.
    Burnett E; Riaz A; Anwari P; Myat TW; Chavers TP; Talat N; Safi N; Aung NNT; Cortese MM; Sultana S; Samsor A; Thu HM; Saddal NS; Safi S; Lin H; Qazi SH; Safi H; Ali A; Parashar UD; Tate JE
    Vaccine; 2023 Nov; 41(48):7220-7225. PubMed ID: 37884416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.
    John J; Kawade A; Rongsen-Chandola T; Bavdekar A; Bhandari N; Taneja S; Antony K; Bhatnagar V; Gupta A; Kabra M; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A104-9. PubMed ID: 25091662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies.
    Rosillon D; Buyse H; Friedland LR; Ng SP; Velázquez FR; Breuer T
    Pediatr Infect Dis J; 2015 Jul; 34(7):763-8. PubMed ID: 26069948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis.
    Yung CF; Chong CY; Thoon KC
    Drug Saf; 2016 Aug; 39(8):745-8. PubMed ID: 27067440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.